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Abstract 
Chemical composition and biological properties of aqueous and ethanolic extracts of 
Inonotus obliquus (Pers.:Fr.) Pilat from different origins, i.e. of Finland, Russia, and 
Thailand, were studied. Concerning biological activity, antimicrobial, antiqourum, 
antioxidative, and antitumor and cytotoxic effects were tested. Oxalic acid was found as the 
main organic acid, with the highest amount in Russian aqueous extract. Gallic, protocatechuic 
and p-hydroxybenzoic acids were detected in all samples. I. obliquus extracts showed high 
antioxidant and antimicrobial activity. Extracts were tested at subMIC for anti-quorum 
sensing (AQS) activity in Pseudomonas aeruginosa and all of them showed definite AQS 
activity. The assays were done using twitching and swarming of bacterial cultures, as well as 
the amount of produced pyocyanin as QS parameters. All the extracts possessed good 
antitumor effect on four cells lines and did not show hepatotoxicity on porcine liver primary 
cells designed as PLP2. As the I. obliquus presence in Chaga conks is limited, further 
purification is necessary to draw quantitative conclusions. The presence of AQS activity in 
medicinal mushrooms suggests a broader anti-infectious disease protection  than only 
immunomodulatory effects.  
Keywords: Inonotus obliquus; Chemical characterization; Antioxidant properties; 
Antimicrobial activity; Antiqourum effect; Antitumor activity; Cytotoxic effect. 
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Introduction 
In the present study we searched for comparable bioactive effects in extracts prepared from 
the well known medicinal mushroom Inonotus obliquus (Pers.:Fr.) Pilat, commonly known as 
Chaga. This mushroom is the hyperplastic conk consisting of wood and mycelium that occurs 
on Birch after infection and invasive growth of the fungus. Extracts of Chaga have been used 
in China, Korea, Russia and the Baltics for their presumed antibacterial, hepatoprotective, 
anti-inflammatory, antitumor, and antioxidant activities (Lemieszek et al. 2012). In vitro, the 
properties of Chaga were found to be non-toxic and mostly antiviral (Ahwad Ali et al. 2003), 
antioxidative (Nakajima et al. 2007) and antiinflammatory (Kim et al. 2007).  Song et al 
(2007) found opposite results showing that its extract was both toxic and proinflammatory in 
macrophages in vitro. Artificially induced acute colitis in mice could be cured by oral 
administration of Chaga extract (Mishra et al. 2012), suggesting suppression of inflammatory 
cytokines. No clear antibiotic effects were reported in the scientific literature for Chaga until 
now.  
Quorum sensing (QS) is a communication system between individuals or individual cells that 
allows recognizing and reacting to the size of the surrounding population. Among QS 
controlled activities of bacteria, coordination of gene expression will allow different forms of 
defense against competitors, and of adaptation to changing environments (Ward et al. 2012). 
Bacteria as Pseudomonas aeruginosa use small diffusible signaling molecules that regulate 
expression of various genes including those for swarming motility, virulence, cell 
aggregation and production of polysaccharides that protect bacterial biofilms (Danchin et al. 
2004, Rasmussen and Givskov, 2006, Fiqua et al. 2001). At least 65 % of all the infectious 
diseases are associated with bacterial biofilms (Fiqua et al. 2001). Bacteria apply QS based 
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mechanisms for their protection against antibiotics and are able to rapidly transfer antibiotic 
resistance throughout their own species as well as to different species.  Each year in the 
United States, at least 2 million people become infected with bacteria that are resistant to 
antibiotics and at least 23000 people die each year as a direct result of these infections (CDC, 
2013). Clostridium difficile, carbapenem-resistant Enterobacteriaceae (CRE) and drug-
resistant Neisseria gonorrhoeae were considered the most urgent threats, and multidrug-
resistant Acinetobacter, drug-resistant Campylobacter, extended spectrum β-lactamase 
producing Enterobacteriaceae (ESBLs), multidrug-resistant Pseudomonas aeruginosa, 
methicillin-resistant Staphylococcus aureus (MRSA) and drug-resistant tuberculosis were 
also among serious threats (CDC, 2013). The rapid emergence of multiple resistances against 
the present broad spectrum antibiotics used for infectious disease needs immediately search 
for alternatives.  Non-toxic natural products that can inhibit microbial quorum sensing and 
thereby stop the appearance of new antibiotic resistant bacterial strains could be such an 
alternative. 
Recently we have described direct antibiotic effects as well as anti-QS properties of extracts 
of the well known medicinal mushroom Agaricus blazei Murill (ABM) against various 
bacteria (Stojkovic et al. 2014). Based on its immunomodulatory effects, ABM was 
previously found to show protective activity against bacterial disease (Rumbaugh et al. 2009, 
Coates et al. 2002, CDC, 2013, Stojkovic et al. 2014). Antimicrobial effects against 
Mycobacterium tuberculosis, M. bovis and Streptococcus pneumoniae had been related with 
the immune system (Coates et al. 2002, Stojkovic et al. 2014), but this was contradicted by 
the study of Fantuzzi et al. (2011) who described that ABM extract did not promote 
immunostimulation and protection during experimental Salmonella enterica infection in 
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mice. The finding of Fantuzzi et al. (2011) was a good reason for us to look for possible anti-
QS properties of ABM extracts. MIC’s and MBC’s of these extracts turned out equal to or 
better for inactivation of P. aeruginosa than those of ampicillin and streptomycin. The effect 
was caused by anti-QS compounds present in the extracts of Agaricus blazei (Sokovic et al., 
2014).  
In the present work, we report the chemical composition, antioxidant, antimicrobial, anti-QS 
and antitumor activities of extracts of I. obliquus wild samples obtained from Russia, Finland 
and Thailand. 
Material and methods 
Mushroom material  
Wild Inonotus obliquus (Thailand) fruiting bodies were obtained from the Natural Medicinal 
Mushroom Collection of the Faculty of Biology of Mahasarakham University, Thailand, and 
had been identified by Prof. Usa Klinhom. Wild I. obliquus (Russia) was obtained from Life 
Extension Asia, Singapore, and was (re)identified by one of us (J.G.). Wild I. obliquus 
(Finland) was bought from COCOVI Import of Kihnio, Finland and (re)identified by one of 
us (LJLDVG). The three biotypes (IOR14-0018, IOF14-0019, IOT13-0007) have been 
conserved in the mycotheque of the Mycological laboratory, Institute for biological research 
Sinisa Stankovic, University of Belgrade. 
The samples were lyophilized (LH Leybold, Lyovac GT2, Frenkendorf), reduced to a fine 
dried powder (20 mesh) and mixed to obtain homogeneity. 
Standards and reagents  
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Acetonitrile 99.9% was of HPLC grade from Fisher Scientific (Lisbon, Portugal). The 
standards of organic acids and phenolic compounds, trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid), phosphate buffered saline (PBS), acetic acid, 
ellipticine, sulforhodamine B (SRB), trypan blue, trichloroacetic acid (TCA) and Tris were 
purchased from Sigma (St. Louis, MO, USA),. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) was 
obtained from Alfa Aesar (Ward Hill, MA, USA). Mueller-Hinton agar (MH) and malt agar 
(MA) were obtained from the Institute of Immunology and Virology, Torlak (Belgrade, 
Serbia). Dimethylsulfoxide (DMSO) was purchased from Merck KGaA (Darmstadt, 
Germany). Foetal bovine serum (FBS), L-glutamine, Hank’s balanced salt solution (HBSS), 
trypsin-EDTA (ethylenediaminetetraacetic acid), nonessential amino acids solution (2 mM), 
penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively), DMEM media 
was from Hyclone (Logan, Utah, USA). Methanol and all other chemicals and solvents were 
of analytical grade and purchased from common sources. Water was treated in a Milli-Q 
water purification system (TGI Pure Water Systems, Greenville, SC, USA).  
Extracts preparation 
Hot aqueous extraction: The material of Inonotus obliquus conks was ground to a fine 
powder with a grinder. The dry powder (25 g/0.5 l water) was heated for 2 h at 80°C. The 
extract was centrifuged at 3000 rpm for 15 min and filtered through Whatman no. 4 filter 
paper; upon which the filtrate was concentrated in an evaporator at 40 °C (rotary evaporator 
Buchi R-210, Flawil, Switzerland) to dryness (Hu et al. 2009). Ethanolic extraction: The 
residue from hot aqueous extraction was extracted in 70 % ethanol at 70°C temperature 
overnight. The extract was then centrifuged at 3000 rpm for 15 min and filtered through the 
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Whatman no. 4 filter paper and dried by a rotary evaporator (Buchi R-210, Flawil, 
Switzerland) under vacuum at 40°C (Hu et al. 2009).  
 
Chemical composition of the extracts 
Organic acids. Organic acids were determined by ultra fast liquid chromatography (UFLC, 
Shimadzu 20A series) coupled with a photodiode array detector (PDA), after dissolving each 
extract in metaphosphoric acid (4%), at a known concentration (Barros et al., 2013). The 
organic acids were quantified by the comparison of the area of their peaks recorded at 215 nm 
with calibration curves obtained from commercial standards of each compound. The results 
were expressed in mg per g of extract. 
Phenolic compounds. Phenolic acids and related compounds were determined using the 
UFLC mentioned above (Barros et al., 2009), after dissolving the aqueous extract in water 
and ethanolic extract in 20% aqueous ethanol, at a known concentration. Detection was 
carried out in a photodiode array detector (PDA), using 280 nm as the preferred wavelength. 
The phenolic acids and related compounds were quantified by comparison of the area of their 
peaks with calibration curves obtained from commercial standards of each compound. The 
results were expressed in mg per g of extract. 
Evaluation of the antioxidant potential of the extracts 
General. Successive dilutions were made from the stock solution of aqueous and ethanolic 
extracts in water and ethanol, respectively and further submitted to different in vitro assays to 
evaluate the antioxidant activity of the samples (Reis et al. 2012). The sample concentrations 
providing 50% of antioxidant activity or 0.5 of absorbance (EC50) were calculated from the 
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graphs of antioxidant activity percentages (DPPH, β-carotene/linoleate and TBARS assays) 
or absorbance at 690 nm (ferricyanide/Prussian blue assay) against sample concentrations. 
Trolox was used as standard. 
Folin-Ciocalteu assay. The extract solution (1 mL) was mixed with Folin-Ciocalteu reagent 
(2.5 mL, previously diluted with water 1:10, v/v) and sodium carbonate (75 g/L, 2 mL). The 
tubes were vortex mixed for 15 s and allowed to stand for 30 min at 40°C for colour 
development. Absorbance was then measured at 765 nm (Analytikjena spectrophotometer; 
Jena, Germany). Gallic acid was used to obtain the standard curve and the reduction of Folin-
Ciocalteu reagent by the samples was expressed as mg of gallic acid equivalents (GAE) per g 
of extract. 
Reducing power or ferricyanide/Prussian blue assay. The extract solutions with different 
concentrations (0.5 mL) were mixed with sodium phosphate buffer (200 mmol/L, pH 6.6, 0.5 
mL) and potassium ferricyanide (1% w/v, 0.5 mL). The mixture was incubated at 50°C for 20 
min, and trichloroacetic acid (10% w/v, 0.5 mL) was added. The mixture (0.8 mL) was 
poured in the 48 wells plate, the same with deionised water (0.8 mL) and ferric chloride 
(0.1% w/v, 0.16 mL), and the absorbance was measured at 690 nm in ELX800 Microplate 
Reader (Bio-Tek Instruments, Inc; Winooski, VT, USA). 
DPPH radical-scavenging activity assay. The reaction mixture was made in a 96 wells plate 
and consisted of 30 µL of a concentration range of the extract and 270 µL methanol 
containing DPPH radicals (6×10-5 mol/L). The mixture was left to stand for 1 h in the dark, 
and the absorption was measured at 515 nm in ELX800 Microplate Reader. The radical 
scavenging activity (RSA) was calculated as a percentage of DPPH discolouration using the 
	   9	  
equation: % RSA = [(ADPPH-AS)/ADPPH] × 100, where AS is the absorbance of the solution 
containing the sample and ADPPH is the absorbance of the DPPH solution.  
Inhibition of β-carotene bleaching or β-carotene/linoleate assay. A solution of β-carotene 
was prepared by dissolving β-carotene (2 mg) in chloroform (10 mL). Two millilitres of this 
solution were pipetted into a round-bottom flask. The chloroform was removed at 40ºC under 
vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water (100 
mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) of this emulsion were 
transferred into test tubes containing 0.2 mL of a concentration range of the extract. The 
tubes were shaken and incubated at 50ºC in a water bath. As soon as the emulsion was added 
to each tube, the zero time absorbance was measured at 470 nm. β-Carotene bleaching 
inhibition was calculated using the following equation: Absorbance after 2h of assay/initial 
absorbance) × 100. 
Thiobarbituric acid reactive substances (TBARS) assay. Porcine (Sus scrofa) brains were 
obtained from official slaughtering animals, dissected, and homogenized with a Polytron in 
ice cold Tris-HCl buffer (20 mM, pH 7.4) to produce a 1:2 w/v brain tissue homogenate 
which was centrifuged at 3000g for10 min. An aliquot (100 µL) of the supernatant was 
incubated with 200 µL samples of a concentration range of the extract in the presence of 
FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL) at 37ºC for 1 h. The reaction 
was stopped by the addition of trichloroacetic acid (28% w/v, 500 µL), followed by 
thiobarbituric acid (TBA, 2%, w/v, 380 µL), and the mixture was then heated at 80ºC for 20 
min. After centrifugation at 3000 g for 10 min to remove the precipitated protein, the color 
intensity of the malondialdehyde (MDA)-TBA complex in the supernatant was measured by 
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its absorbance at 532 nm. The inhibition ratio (%) was calculated using the following 
formula: Inhibition ratio (%) = [(A - B)/A] × 100%, where A and B were the absorbance of 
the control and the sample solution, respectively. 
 
Antibacterial activity of the extracts 
Bacteria were routinely grown in Luria-Bertani (LB) medium (1% w/v NaCl, 1% w/v 
tryptone, 0.5% w/v yeast extract) with shaking (220 rpm) and cultured at 37°C. The fungi 
were maintained on potato dextrose agar (PDA), malt agar (MA) and Sabouraud agar (SBA). 
The cultures were stored at +4°C and subcultured once a month.  
The Gram-positive bacteria Staphylococcus aureus (ATCC 6538), Bacillus cereus (clinical 
isolate), Micrococcus flavus (ATCC 10240) and Listeria monocytogenes (NCTC 7973), and 
the Gram-negative bacteria Pseudomonas aeruginosa (ATCC 27853), Salmonella 
typhimurium (ATCC 13311), Escherichia coli (ATCC 35210), and Enterobacter cloacae 
(human isolate), were used. The antibacterial assay was carried out by a microdilution 
method (CLSI, 2009; Tsukatani et al. 2012). The bacterial suspensions were adjusted with 
sterile saline to a concentration of 1.0×105 CFU/mL. Ethanolic and aqueous extracts of I. 
obliquus from Russia, Finland and Thailand were dissolved in 5% DMSO solution containing 
0.1% Tween 80 (v/v) (10 mg/mL) and immediately added in Tryptic Soy broth (TSB) 
medium (100 µL) with bacterial inoculum (1.0×104 CFU per well). The lowest 
concentrations without visible growth (at the binocular microscope) were defined as 
concentrations that completely inhibited bacterial growth (MICs). The MICs obtained from 
the susceptibility testing of various bacteria to tested extracts were determined also by a 
colorimetric microbial viability assay based on reduction of INT ((p-iodonitrotetrazolium 
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violet) [2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium chloride; Sigma]) color and 
compared with positive control for each bacterial strain. The MBCs were determined by 
serial sub-cultivation of 2 µL into microtitre plates containing 100 µL of broth per well and 
further incubation for 24 h. The lowest concentration with no visible growth was defined as 
the MBC, indicating 99.5% killing of the original inoculum. The optical density of each well 
was measured at a wavelength of 655 nm by Microplate manager 4.0 (Bio-Rad Laboratories) 
and compared with a blank (broth medium plus diluted extracts) and the positive control. 
Streptomycin (Sigma P 7794) and Ampicillin (Panfarma, Belgrade, Serbia) were used as 
positive controls (1 mg/mL in sterile physiological saline). Five percent DMSO was used as a 
negative control.  
 
Antifungal activity of the extracts 
Aspergillus fumigatus (human isolate), Aspergillus versicolor (ATCC 11730), Aspergillus 
ochraceus (ATCC 12066), Aspergillus niger (ATCC 6275), Trichoderma viride (IAM 5061), 
Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112) and 
Penicillium verrucosum var. cyclopium (food isolate), were used. In order to investigate the 
antifungal activity of ethanolic and water extracts of three different samples of I. obliquus, a 
modified microdilution technique was used (Espaniel-Ingroff, 2001).The fungal spores were 
washed from the surface of agar plates with sterile 0.85% saline containing 0.1% Tween 80 
(v/v) and spore suspension was adjusted with sterile saline to a concentration of 1.0×105. 
Ethanolic and aqueous extracts of I. obliquus from Russia, Finland and Thailand were 
dissolved in 5% DMSO solution containing 0.1% Tween 80 (v/v) (10 mg/mL) and 
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immediately added in broth Malt medium with inoculum (0.2-6.0 mg/mL). The lowest 
concentrations without visible growth (at the binocular microscope) were defined as MICs. 
The fungicidal concentrations (MFCs) were determined by serial subcultivation of 2 µL of 
tested compounds dissolved in medium and incubated for 72 h at 28°C. The lowest 
concentration with no visible growth was defined as MFC indicating 99.5% killing of the 
original inoculum. DMSO was used as a negative control, and commercial fungicides, 
bifonazole (Srbolek, Belgrade, Serbia) and ketoconazole (Zorkapharma, Šabac, Serbia), were 
used as positive controls (1-3000 µg/mL). Five percent DMSO was used as a negative 
control.  
Antiquorum sensing (AQ) activity of the extracts 
Bacterial strains, growth media and culture conditions. P. aeruginosa PA01 (ATCC 27853) 
used in this study is from the collection of the Mycoteca, Institute for Biological Research 
"Sinisa Stankovic", Belgrade, Serbia. Bacteria were routinely grown in Luria-Bertani (LB) 
medium (1% w/v NaCl, 1% w/v Tryptone, 0.5% w/v yeast extract) with shaking (220 rpm) 
and cultured at 37 °C. 
 
Twitching and flagella motility  
After growth in the presence or absence of ethanolic and aqueous extracts of I. obliquus 
(subMIC, 0.5 MIC), streptomycin and ampicillin (subMIC), the cells of P. aeruginosa PA01 
were washed twice with sterile PBS and resuspended in PBS at 1 x 108 cfu/mL (OD of 0.1 at 
660 nm). Briefly, cells were stabbed into a nutrient agar plate with a sterile toothpick and 
incubated overnight at 37° C. Plates were then removed from the incubator and incubated at 
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room temperature for two more days. Colony edges and the zone of motility were measured 
with a light microscope (O’Toole and Kolter, 1998a,b).  
SubMIC (0.5 MIC; 0.25-0.75 mg/mL) of extracts were mixed into 10 mL of molten MHA 
(Mueller-Hinton agar) and poured immediately over the surface of a solidified LBA plate as 
an overlay. The plate was point inoculated with an overnight culture of PAO1 once the 
overlaid agar had solidified, and was incubated at 37° C for 3 days. The extent of swimming 
was determined by measuring the area of the colony (Sandy and Foong-Yee, 2012). The 
experiment was done in triplicate and repeated two times. The colony diameters were 
measured three times in different direction and values were presented as a mean values ± SE. 
Inhibition of synthesis of Pseudomonas aeruginosa PA01 Pyocyanin   
Overnight culture of P. aeruginosa PA01 was diluted to OD600 nm 0.2. Then, ethanolic and 
aqueous extracts of I. obliquus were dissolved in 5% of DMSO (0.25-0.75 mg/mL), added to 
P. aeruginosa (5.00 mL) and incubated at 37 °C for 24 h. The treated culture was extracted 
with chloroform (3 mL), followed by mixing the chloroform layer with 0.2 M HCl (1 mL). 
Absorbance of the extracted organic layer was measured at 520 nm using a Shimadzu 
UV1601 spectrophotometer (Kyoto, Japan) (Sandy and Foong-Yee, 2012). The experiment 
was done in triplicate and repeated two times. The values were expressed as ratio 
(OD520/OD600) x 100. 
 
Cytotoxicity of the extracts for tumor cell lines and non-tumor liver cells primary cultures 
The aqueous and ethanolic extracts were re-dissolved in water at 8 mg/mL to obtain a more 
efficient dissolution. Successive dilutions were made from the stock solution and tested 
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against five human tumor cell lines: MCF-7 (breast carcinoma), NCI-H460 (non-small cell 
lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma). Cells were 
routinely maintained as adherent cell cultures in RPMI-1640 medium containing 10% heat-
inactivated FBS (MCF-7, NCI-H460, HeLa and HepG2) and 2 mM glutamine (, at 37ºC, in a 
humidiﬁed air incubator containing 5% CO2. Each cell line was plated at an appropriate 
density (7.5×103 cells/well for MCF-7 and NCI-H460  or 1.0×104 cells/well for HeLa and 
HepG2) in 96-well plates and allowed to attach for 24 h. Cells were then treated for 48h with 
the diluted sample solutions. Following this incubation period, the adherent cells were ﬁxed 
by adding cold 10% trichloroacetic acid (TCA, 100 µL) and incubated for 60 min at 4 ºC. 
Plates were then washed with deionized water and dried; sulforhodamine B solution (0.1% in 
1% acetic acid, 100 µL) was then added to each plate well and incubated for 30 min at room 
temperature. Unbound SRB was removed by washing with 1% acetic acid. Plates were air 
dried, the bound SRB was solubilised with 10 mM Tris (200 µl, pH 7.4) and the absorbance 
was measured at 540 nm (Monks et al., 1991) in the microplate reader mentioned above. The 
results were expressed in GI50 values (sample concentration that inhibited 50% of the net cell 
growth). Ellipticine was used as positive control. 
For hepatotoxicity evaluation, a cell culture was prepared from a freshly harvested porcine 
liver obtained from a local slaughter house. It was designed as PLP2. Brieﬂy, the liver tissues 
were rinsed in Hank’s balanced salt solution containing 100 U/mL penicillin and 100 µg/mL 
streptomycin and divided into 1×1 mm3 explants. Some of these explants were placed in 25 
cm2 tissue ﬂasks in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% 
fetal bovine serum, 2 mM nonessential amino acids and 100 U/mL penicillin, 100 mg/mL 
streptomycin and incubated at 37ºC with a humidiﬁed atmosphere containing 5% CO2. The 
	   15	  
medium was changed every 2 days. Cultivation of the cells was continued with direct 
monitoring every 2-3 days using a phase contrast microscope. Before conﬂuence, cells were 
sub-cultured and plated in 96-well plates at a density of 1.0×104 cells/well, and cultivated in 
DMEM medium with 10% FBS, 100 U/mL penicillin and 100 µg /mL streptomycin (Abreu 
et al., 2011). Cells were treated for 48h with the different diluted sample solutions and the 
same procedure described in the previous section for Sulforhodamine B colorimetric (SRB) 
assay was followed. The results were expressed in GI50 values (sample concentration that 
inhibited 50% of the net cell growth). Ellipticine was used as positive control. 
Statistical analysis 
For each species, three samples were used and all the assays were carried out in triplicate. 
The results were expressed as mean values and standard errors, and analyzed using one-way 
analysis of variance (ANOVA) followed by Tukey’s HSD Test with α = 0.05. This analysis 
was carried out using SPSS v. 20.0 program. 
 
Results and discussion 
Chemical characterization, antioxidant and antimicrobial effects I. obliquus extracts 
The yields of ethanolic extracts were 1, 2.4 and 1.3 g for samples from Russia, Finland and 
Thailand, respectively, while of, aqueous extracts were 2, 5.5. and 0.5 g  for the same 
samples, in all cases starting from 25 g of dry powder.  
Oxalic acid was the only organic acid detected in the extracts (6.72-97.59 mg/g extract). The 
phenolic acids found were gallic, protocatechuic and p-hydroxybenzoic acids, as also the 
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related compound cinnamic acid (Table 1). Gallic acid was only found in both, aqueous and 
ethanolic, extracts from Thailand (0.32 and 0.20 mg/g extract), and protocatechuic acid was 
detected in all samples except the aqueous extract from Finland (0.07-0.94 mg/g extract). p-
Hydroxybenzoic acid was found in all samples (0.43-59.20 mg/g extract) and the related 
compound cinnamic acid was detected in all samples except the aqueous extract from 
Thailand (0.03-0.40 mg/g extract).  
Regarding the antioxidant potential (Table 2), it might be concluded that the ethanolic extract 
of I. obliquus from Thailand revealed the lowest EC50 values for Ferrocyanide/Prussian blue 
(0.07 mg/mL), DPPH radical-scavenging activity (0.23 mg/mL), β-carotene bleaching 
inhibition (0.13 mg/mL) as well as for TBARS inhibition (0.08 mg/mL) assays. I. obliquus 
proved to have high potential for antioxidant purposes, since the obtained EC50 values were 
lower than those reported for other wild edible species (Pereira et al., 2012). In previous 
study of antioxidant activity of mycelia of I. obliquus (Debnath et al., 2013), the scavenging 
activity of water, ethanol and methanol extracts on DPPH’s were determined, and it was 
concentration dependent. The scavenging activities were ranged from 12.50–200 mg/mL, 
respectively. Therefore, the all extracts showed higher scavenging activity on DPPH• radical. 
The IC50 (concentration at which 50% of DPPH•s are scavenged) were 18.96, 16.25 and 
24.90 mg/mL for the water, ethanol and methanol extracts, respectively.  
The results for antibacterial activity of ethanol and aqueous extracts of I. obliquus are 
presented in Table 3. The ethanolic extracts of I. obliquus from Russia, Finland and Thailand 
exhibited inhibitory effects at 0.30-3.00 mg/mL, 0.75-3.00 mg/mL, 0.50-2.25 mg/mL, 
respectively. A bactericidal effect was achieved at 1.50-6.00 mg/mL, 1.50-6.00 mg/mL and 
0.75-3.00 mg/mL, respectively. The highest antibacterial effect was observed for ethanolic 
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extract obtained from Thailand. The aqueous extracts showed inhibitory activity at 0.40-3.00 
mg/mL, 0.75-3.75 mg/mL and 0.75-3.00 mg/mL from each one of the mentioned origins, and 
bactericidal activity at 1.50-6.00 mg/mL, 1.50-7.50 mg/mL and 1.50-6.00 mg/mL. The 
sample from Russia exhibited the highest antibacterial activity. The most sensitive bacteria to 
the extracts were S. aureus and B. cereus, while the most resistant ones were L. 
monocytogenes, E. coli and E. cloacae. All tested extracts exhibited lower antibacterial 
activity than the control antibiotics, with exception of ethanolic extract from Thailand against 
P. aeruginosa (Table 3). 
Regarding the antifungal activity (Table 4), the results were quite similar. All tested extracts 
showed again considerable antifungal effects on all tested fungi. Inhibitory effect of ethanolic 
extracts prepared with samples from Russia, Finland and Thailand was 0.40-1.50 mg/mL, 
0.75-1.50 mg/mL and 0.40-1.50 mg/mL, respectively. A fungicidal effect was achieved at 
0.75-3.00 mg/mL, 1.50-3.00 mg/mL and 0.75-.3.00 mg/mL, respectively. Aqueous extracts 
of the tested samples showed inhibition at 0.20-0.75 mg/mL, 0.20-0.75 mg/mL and 0.20-1.50 
mg/mL, respectively. A fungicidal activity of these extracts was observed at 0.75-3.00 
mg/mL, 0.40-1.50 mg/mL and 0.40-3.00 mg/mL, respectively. The most susceptible fungus 
was T. viride, while the most resistant were A. niger and A. fumigatus. The antifungal effect 
of tested extracts on P. ochrochloron and T. viride was higher than the one observed for 
ketoconazole (Table 4). 
 
Antiquorum sensing activity and cytotoxicity of I. obliquus extracts 
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Many mechanisms of actions have been proposed to interfere with the quorum sensing 
system such as inhibition of biosynthesis of autoinducer molecules, inactivation or 
degradation of the autoinducer, interference with the signal receptor, and inhibition of the 
genetic regulation system (Rasmussen and Givskov, 2006). 
In addition to QS, the initiation of biofilm formation by P. aeruginosa depends on two cell-
associated structures; the flagellum and type IV pili (O’Toole and Kolter, 1998a,b). The 
flagellum is responsible for swarming motility while the type IV pili are responsible for 
twitching motility (Henrichsen, 1972). Both types of motility are important in the initial 
stages of biofilm formation by P. aeruginosa (O’Toole and Kolter, 1998a,b). Therefore, we 
tried to determine if I. obliquus extracts can influence either one or both motilities. On 
swarming plates, the motile strain PAO1 was used as the 100% standard (control) for 
motility, while the Petri dishes with the same strain plus ethanol and aqueous extracts of I. 
obliquus were compared with the control. The normal colonies of P. aeruginosa, i.e. in the 
absence of extracts, were flat with a rough appearance displaying irregular colony edges (Fig. 
1G) and a hazy zone surrounding the colony. The cells grew in a very thin layer. After 2 days 
of incubation at ambient temperature, colony expansion occurred very rapidly due to 
twitching motility; the control P. aeruginosa isolates produced swimming zones (Table 5) of 
12.6±1.0 mm. Statistically they all had the same colony size; the color of all treated samples 
was however different and went from white to light brown. Microscopically it was seen that 
bacteria grown with EIOR and AIOR extracts had reduced twitching motility. These colonies 
were incapable of producing such a twitching zone and had almost round, smooth, regular 
colony edges, the flagella were reduced both in size and in numbers (Fig. 1A, B) and the 
colony diameter was also reduced in comparison with control (10.7 mm). EIOR caused flatter 
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protrusions than AIOR and the colony had a different color. EIOF extract influenced the 
colony color (orange) and diameter (10.3 mm), while also the protrusions were flatter. AIOF 
extract showed slightly lower antiquorum effect than EIOF. Colony color was light brown, 
diameter was reduced (10.5 mm) but the protrusions was only partly reduced (Fig. 1D). EIOT 
extract induced light yellow color of colony and diameter was reduced to 11.3 mm, and 
protrusions were flatter (Fig. 1E). AIOT extract showed lower AQ effect; colony color was 
white yellow, diameter was 11.6 mm and protrsions partly reduced (Fig. 1F). Streptomycin 
changed colony color in white, reduced diameter to 5.0 mm, and completely reduced 
protrusions (Fig. 1H), while Ampicillin changed color in white, and slightly reduced 
diameter to 12.0 mm and did not affect the formation of protrusions at all (Fig. 1I). It can be 
seen that extracts from Russia in general showed the highest reduction of protrusions. The 
best diameter reduction was shown by both Finland extracts, and the highest protrusion 
reduction was also shown by one of the Finland extracts, EIOF. Thailand extracts possessed 
the lowest antiqourum activity of the three different extract origins investigated; colony 
diameter was reduced in low percentage, protrusions were reduced but still wide and merged 
by EIOT, while AIOT reduced diameter in even lower percentage, protrusions were slightly 
reduced, still long and wider than AIOF but narrower than the untreated control (Fig. 1A-I). I 
think we should do much more to explain what happens here, especially why this is important 
for the formation of biofiilms. Maybe there are inhibitors of flagellar growth. I can imagine  
that we start point inoculation  and cover a sector of  the plate with a new agarlayer  after   
some hours and again later  to see what happens. I think we have to make sure that the 
readers see the importance  of preventing swarming.  I am not experienced in bacteriology, 
but I will think of it. Let’s discuss. 
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The activity against pyocyanin production in a flask assay was used to quantify quorum 
sensing inhibitory activity of the ethanol and aqueous extracts of I. obliquus. The effect of 
extracts on production pyocyanin of P. aeruginosa (PAO1) was tested in subMIC 
concentration (Figure 2). The ethanolic and aqueous extracts of I. obliquus demonstrated 
concentration-dependent pyocyanin inhibitory activity. The pyocyanin assays revealed that 
subMIC amounts of extracts produced less (102-141%) pyocyanin than PAO1 (145.00%). 
Streptomycin reduced the production of pyocyanin in 70.00%, while ampicillin stimulated 
production of extracts 1.5 times (215.00%). All tested extracts showed reduction of 
pyocyanin production but only in low amount. The highest reduction of pyocyanin 
production could be seen for extracts from Finland, especially for ethanolic extract (Figure 
2).  
The results obtained for cytotoxic activity in human tumor cell lines are presented in Table 6. 
The lowest GI50 values were obtained for both Russian extracts in all cell lines except NCI-
H460, which proved to be more sensitive to the extracts (80.93-91.20 µg/mL). All tested 
extracts were particularly active on breast carcinoma cells (MCF-7; 92.65-239.43 µg/mL), 
non-small cell lung cell line (NCI-H460; 91.20-267.27 µg/mL), with exception of ethanolic 
extract from Finland, cervical cell line (HeLa; 217.36-318.19 µg/mL) with exception of 
aqueous extract from Russia, and hepatocellular carcinoma cells (HepG2; 94.24-336.48 
µg/mL). At the mentioned concentrations, the different fractions did not show toxicity against 
non-tumor liver primary cells (PLP2; GI50 > 400 µg/mL).  
 
In summary, our study indicated that aqueous and ethanolic extracts of I. obliquus obtained 
from three different localities possessed clear antioxidant, antimicrobial and anti-quorum 
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sensing activity, as well as antitumor effects without toxicity for non-tumor liver cells. It 
should be noted that extracts were prepared from Chaga conks, hyperplastic structures from 
Birch cortex that consist only partly of fungal material. One of us (LJLDVG) estimated the 
amount of mycelium in the conks on 10% only, based on microscopical observation. This 
indicates that further purification of the extracts is needed to draw definite conclusions on the 
possible anti-QS activity of Chaga and of I. obliquus extracts. Anti-quorum sensing property 
of this “mushroom” derived material may play an important role in antibacterial activity and 
could offer an additional strategy for fighting bacterial infection. Inhibition of different kind 
of bacteria and fungi, and bacterial quorum sensing, but also antitumor effect, offers a new 
strategy for the using of this mushroom as a medicinal mushroom. 
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Table 1. Organic and phenolic acids in I. obliquus aqueous and ethanolic extracts  (mean ± SD). 
 
nd- not detected. In each row different letters mean significant differences (p<0.05). 
 
 Russia  Finland  Thailand 
 Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Organic acids  (mg/g extract) 
Oxalic acid 97.59±0.39a 24.15±0.12d 55.62±0.07b 9.50±0.02e 32.86±0.02c 6.72±0.04f 
Phenolic acids (mg/g extract) 
Gallic acid nd nd nd nd 0.32±0.01a 0.20±0.01b 
Protocatechuic acid 0.13±0.01c 0.07±0.01d nd 0.12±0.01c 0.94±0.01a 0.75±0.01b 
p-hydroxybenzoic acid 0.43±0.01f 2.77±0.01e 4.85±0.01d 7.41±0.01c 59.20±0.02a 57.48±0.01b 
Total phenolic acids 0.56±0.01f 2.84±0.01e 4.85±0.01d 7.53±0.01c 60.47±0.02a 58.43±0.01b 
Cinamic acid 0.03±0.01d 0.06±0.01c 0.06±0.01c 0.08±0.01b nd 0.40±0.01a 
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Table 2. Antioxidant activity of I. obliquus aqueous and ethanolic extracts (mean ± SD). .  
Concerning the Folin-Ciocalteu assay, higher values mean higher reducing power; for the other assays, the results are presented in EC50 values, what means that 
higher values correspond to lower reducing power or antioxidant potential. EC50: Extract concentration corresponding to 50% of antioxidant activity or 0.5 of 
absorbance for the Ferricyanide/Prussian blue assay. Trolox was used as standard (EC50 values were 0.04 mg/mL for reducing power and DPPH scavenging 
activity; and 0.02 mg/mL for β-carotene/linoleate and TBARS assays). In each row different letters mean significant statistical differences between samples 
(p<0.05).  
 
 
  Russia Finland  Thailand 
  Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Reducing  power 
Folin-ciocalteu  
(mg GAE/g extract) 
147.44±0.62d 95.70±0.61e 154.79±1.15c 54.38±0.67f 230.69±1.26b 590.87±1.92a 
Ferricyanide/Prussian blue 
(EC50; mg/mL) 
0.30±0.00c 0.69±0.00b 0.29±0.00c 2.68±0.03a 0.15±0.00d 0.07±0.00e 
Radical scavenging 
activity 
DPPH scavenging activity 
(EC50; mg/mL) 
0.48±0.00c 3.21±0.23b 0.53±0.01c 9.22±0.25a 0.23±0.01d 0.23±0.00d 
β-carotene/linoleate 
 (EC50; mg/mL) 
0.55±0.04b 0.48±0.03c 0.48±0.02c 0.40±0.01d 0.59±0.03a 0.13±0.00e 
Lipid peroxidation  
inhibition 
TBARS  
(EC50; mg/mL) 
0.10±0.00c 0.19±0.00b 0.06±0.00f 0.30±0.01a 0.09±0.00d 0.08±0.00e 
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Table 3. Minimum inhibitory (MIC) and bacterial (MBC) concentrations of aqueous and ethanolic extracts of I. obliquus (mg/mL). 
Bacteria 
Russia Finland Thailand Streptomycin Ampicillin 
Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
 
  
Staphylococcus 
aureus 
0.40±0.02d 
1.50±0.07b 
0.30±0.00c 
1.50±0.07b 
0.75±0.02e 
6.00±0.10d 
0.75±0.01e 
1.50±0.10b 
0.75±0.01e 
3.00±0.00c 
0.75±0.00e 
1.50±0.07b 
0.040±0.0007a 
0.090±0.300d 
0.250±0.007b 
0.370±0.010a 
 
Bacillus 
cereus 
1.10±0.07c 
1.50±0.10b 
0.30±0.02a 
1.50±0.07b 
1.40±0.0.7c 
1.80±0.03c 
0.75±0.0.2b 
1.50±0.10b 
0.75±0.02b 
3.00±0.10d 
0.75±0.00b 
1.50±0.01b 
0.090±0.030a 
0.170±0.010a 
0.250±0.030a 
0.370±0.010a 
 
Micrococcus 
flavus 
1.50±0.10c 
3.00±0.30c 
2.25±0.08e 
3.00±0.07c 
1.80±0.07d 
3.75±0.02d 
2.25±0.02e 
3.00±0.10c 
3.00±0.00f 
6.00±0.00e 
1.10±0.07b 
1.50±0.07b 
0.170±0.010a 
0.340±0.010a 
0.250±0.007a 
0.370±0.010a 
Listeria 
monocytogenes 
3.00±0.07e 
6.00±0.10e 
3.00±0.00e 
6.00±0.10e 
3.75±0.08f 
7.50±0.07d 
3.00±0.10e 
6.00±0.00c 
1.10±0.03c 
3.00±0.07b 
2.25±0.05d 
3.00±0.10b 
0.170±0.010a 
0.340±0.010a 
 
0.370±0.010b 
0.490±0.010a 
 
Pseudomonas 
aeruginosa 
1.10±0.03d 
3.00±0.10d 
0.75±0.007c 
1.50±0.07c 
0.75±0.00c 
6.00±0.20e 
0.75±0.007e 
1.50±0.10c 
1.50±0.07e 
3.00±0.10d 
0.50±0.07b 
0.75±0.007b 
0.170±0.010a 
0.340±0.010a 
 
0.740±0.070c 
1.240±0.08c 
 
Salmonella 
typhimurium 
2.25±0.08e 
3.00±0.07e 
0.75±0.02c 
1.50±0.07d 
1.10±0.03d 
3.00±0.00e 
0.75±0.00c 
1.50±0.07d 
1.10±0.03b 
1.50±0.04d 
0.50±0.02d 
0.75±0.00c 
0.170±0.010a 
0.340±0.010a 
 
0.370±0.010b 
0.490±0.007b 
 
Escherichia 
coli 
1.50±0.07e 
6.00±0.20e 
2.25±0.08d 
3.00±0.10c 
3.75±0.08f 
7.50±0.07f 
2.25±0.08d 
3.00±0.00c 
3.00±0.00e 
6.00±0.20d 
1.10±0.03b 
1.50±0.07b 
0.170±0.010a 
0.340±0.01a 
 
0.250±0.007a 
0.490±0.030a 
 
Enterobacter 
cloacae 
3.00±0.10e 
6.00±0.20de 
3.00±0.20e 
6.00±0.30e 
1.10±0.07c 
1.50±0.07b 
1.50±0.07d 
3.00±0.10c 
3.00±0.00e 
6.00±0.20d 
0.75±0.02b 
1.50±0.00b 
0.260±0.010a 
0.520±0.007a 
0.370±0.010a 
0.740±0.010a 
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Table 4. Minimum inhibitory (MIC) and fungicidal (MFC) concentrations of aqueous and ethanolic extracts of I. obliquus (mg/mL). 
Fungi 
Russia Finland Thailand 
Bifonazole Ketoconazole Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Aqueous 
extract 
EtOH 
extract 
Aspergillus 
 fumigatus 
0.75±0.02c 
1.50±0.07c 
0.75±0.00c 
1.5±0.00c 
0.40±0.02b 
1.50±0.10c 
1.50±0.07d 
3.00±0.20d 
0.75±0.007c 
1.50±0.10e 
1.50±0.10d 
3.00±0.00d 
0.150±0.02a 
0.200±0.02a 
0.200±0.000a 
0.500±0.020b 
Aspergillus 
 versicolor 
0.40±0.02c 
0.75±0.00cd 
0.40±0.00c 
0.75±0.02cd 
0.40±0.01c 
0.75±0.02d 
0.75±0.02d 
1.50±0.00e 
0.20±0.00b 
0.40±0.01ab 
1.50±0.07e 
3.00±0.20f 
0.100±0.01a 
0.200±0.02a 
0.200±0.020b 
0.500±0.030bc 
Aspergillus 
 ochraceus 
0.20±0.02a 
0.75±0.02b 
0.75±0.00c 
1.50±0.07e 
0.40±0.02b 
0.75±0.007b 
0.75±0.07e 
1.50±0.07c 
1.50±0.00d 
3.00±0.00e 
0.75±0.02c 
1.50±0.07c 
0.150±0.007a 
0.200±0.000a 
1.500±0.100d 
2.000±0.007d 
Aspergillus 
niger 
0.75±0.02c 
3.00±0.10c 
1.50±0.07d 
3.00±0.20c 
0.40±0.00b 
0.75±0.00b 
1.50±0.07d 
3.00±0.20c 
0.40±0.02b 
0.75±0.01b 
1.50±0.02e 
3.00±0.00e 
0.150±0.070a 
0.200±0.010a 
0.200±0.000a 
0.500±0.000b 
Trichoderma 
viride 
0.40±0.00b 
0.75±0.02c 
0.40±0.02b 
0.75±0.00c 
0.20±0.01a 
0.40±0.01b 
0.75±0.02c 
1.50±0.07e 
0.40±0.02b 
0.75±0.02c 
0.40±0.00b 
0.75±0.02c 
0.150±0.000a 
0.200±0.010a 
1.00±0.100d 
1.00±0.000d 
Penicillium 
funiculosum 
0.40±0.01b 
0.75±0.02c 
0.40±0.00b 
0.75±0.00c 
0.75±0.07c 
1.50±0.10e 
0.75±0.01c 
1.50±0.01de 
0.75±0.00e 
1.50±0.00de 
0.75±0.02c 
1.50±0.10d 
0.200±0.010a 
0.250±0.000a 
0.200±0.020a 
0.500±0.020b 
Penicillium 
ochrochloron 
0.40±0.02b 
0.75±0.01b 
0.75±0.01c 
1.50±0.10c 
0.40±0.00b 
0.75±0.00b 
0.75±0.01c 
1.50±0.10c 
0.75±0.00c 
1.50±0.07c 
0.75±0.01c 
1.50±0.00c 
0.200±0.010a 
0.250±0.010a 
2.500±0.100d 
3.500±0.050d 
Penicillium 
verrucosum 
0.40±0.02c 
0.75±0.00b 
0.75±0.00d 
1.50±0.10c 
0.40±0.01c 
0.75±0.01b 
0.75±0.007d 
1.50±0.10c 
0.75±0.01d 
1.50±0.07b 
0.75±0.00d 
1.50±0.03c 
0.100±0.010a 
0.200±0.007a 
0.200±0.010b 
0.300±0.010a 
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Table 5. Twitching and motility activity of I. obliquus aqueous and ethanolic extracts at MIC 0.5 mg/mL (mean ± SD). 
Agents Colony diameter (mm ± SD) Colony color 
Colony edge on 
microscope 
Aqueous Russia  10.7±0.76 white brown reduced flagella 
EtOH Russia  10.7±1.51 light brown reduced flagella 
Aqueous Finland   10.5±0.65 light brown partly reduced flagella 
EtOH Finland 10.3±0.63 orange reduced flagella 
Aqueous Thailand   11.6±0.06 white yellow slightly reduced flagella 
EtOH Thailand  11.3±0.36 light yellow reduced flagella 
Ampicillin 12.00±1.00 white regular flagella 
Streptomycin 5.0±0.03 white no flagella 
Control P.a. 109 12.6±1.00 green regular flagella 
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Table 6. Antitumor activity of I. obliquus aqueous and ethanolic extracts L (mean ± SD).  
 
GI50 values correspond to the sample concentration achieving 50% of growth inhibition in human tumour cell lines or in liver primary culture PLP2. In each row 
different letters mean significant differences (p<0.05). 
 Russia  Finland  Thailand  
 
Aqueous  
extract 
EtOH 
extract 
Aqueous  
extract 
EtOH 
extract 
Aqueous 
extract   
EtOH 
extract 
Elipticine 
MCF-7 (breast carcinoma) 
(GI50, µg/mL) 
212.10±10.12b 182.61±2.45c 212.03±19.72b 239.43±4.74a 92.65±2.74e 174.32±12.92d 1.21±0.02 
NCI-H460 (non-small cell lung cancer) 
(GI50, µg/mL) 
91.20±5.35d 80.93±13.04e 177.94±6.64b >400 267.27±6.37a 144.33±4.61c 1.03±0.09 
HeLa (cervical carcinoma) 
(GI50, µg/mL) 
>400 245.66±9.34b 224.91±24.42c 217.36±11.95d 318.19±18.19a 225.99±1.95c 0.91±0.11 
HepG2 (hepatocellular carcinoma) 
(GI50, µg/mL) 
336.48±27.96a 228.23±22.78d 281.12±4.15b 247.60±18.66c 217.79±4.46e 94.24±3.61f 1.10±0.09 
Hepatotoxicity 
PLP2 (GI50, µg/mL) 
>400 >400 >400 >400 >400 >400 2.29±0.18 
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Figure 1. Light microscopy of colony edges of P. aeruginosa in twitching motility 
plates, grown in the presence or absence of ethanolic and aqueous extracts of I. 
obliquus 
	  
Light microscopy of colony edges of P. aeruginosa in twitching motility, grown in the presence or absence of I. obliquus (EIO and AIO) 
extracts in concentration of 0.5 MIC. The colonies from the bacteria grown with Russia ethanolic extract (A) and aqueous extract (B) were 
rounded, had a smooth domed shape and lacked a hazy zone surrounding the colony. Colony with the presence of Finland ethanolic extract with 
reduced flagella (C), and with presence of aqueous extract with regular long flagella (D). Colonies with the presence of Thailand ethanolic extract 
with reduced flagella (E) and with aqueous  extract which partly reduced flagella (W). P. aeruginosa produced a flat, widely spread, irregularly 
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shaped colony with regular flagella in the absence of extracts, control (G); P. aeruginosa colony with presence of streptomycin without flagella 
(H) and ampicillin with almost regularly formed flagella (I); Magnification: (A–E) ×100. 
Figure 2. Effects of ethanolic and aqueous extracts at 0.5 MIC of I. obliquus on 
production of pyocyanin by P. aeruginosa (PAO1). 
 
	  
	  
	  
	  
	  
	  
	  
Aqueous extract from Russia (AIOR), Finland (AIOF) and Thailand (AIOT), ethanolic extract from 
Russia (EIOR), Finland (EIOF) and Thailand (EIOT).	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